Amanote Research
Register
Sign In
RhoB and the Cellular Response to Farnesyltransferase Inhibitors: The Search for Clues to Cell Death Mechanisms
Cancer Biology and Therapy
- United States
doi 10.4161/cbt.2.3.397
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Date
May 20, 2003
Authors
Eric Bernhard
Publisher
Informa UK Limited
Related search
RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors
Molecular and Cellular Biology
Cell Biology
Molecular Biology
High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase Inhibitors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Mutant Form of Human Protein Farnesyltransferase Exhibits Increased Resistance to Farnesyltransferase Inhibitors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Diversity Training for Signal Transduction: Leveraging Cell-To-Cell Variability to Dissect Cellular Signaling, Differentiation and Death
Current Opinion in Biotechnology
Bioengineering
Biomedical Engineering
Biotechnology
In Search of a Chlorpyrifos Antidote: Mechanisms Offer Clues
Environmental Health Perspectives
Mutagenesis
Public Health
Environmental
Health
Toxicology
Occupational Health
The Potential of Farnesyltransferase Inhibitors as Cancer Chemotherapeutics
Annual Review of Pharmacology and Toxicology
Toxicology
Pharmacology
AIM2 Activates the Inflammasome and Cell Death in Response to Cytoplasmic DNA
Nature
Multidisciplinary
Cellular Mechanisms in the Immune Response to Malaria in Plasmodium Vinckei-Infected Mice.
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Simultaneous Exposure of Transformed Cells to SRC Family Inhibitors and CHK1 Inhibitors Causes Cell Death
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology